We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

92 hedge funds and large institutions have $212M invested in Trinity Biotech in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 40 increasing their positions, 28 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 28

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

0% more funds holding

Funds holding: 92 → 92 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

34% less capital invested

Capital invested by funds: $323M → $212M (-$111M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $186K

Holders
92
Holders Change
–
Holders Change %
0%
% of All Funds
2.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
40
Reduced
28
Closed
7
Calls
–
Puts
$186K
Net Calls
-$186K
Net Calls Change
-$7K

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$10M
2
Boston Partners
Boston Partners
Massachusetts
+$6.74M
3
PIM
Paradice Investment Management
Colorado
+$3M
4
Millennium Management
Millennium Management
New York
+$2.93M
5
SI
Stephens Inc
Arkansas
+$1.9M

Top Sellers

Rank Fund Capital Flow
1
William Blair & Company
William Blair & Company
Illinois
-$11.9M
2
CAM
Cortina Asset Management
Wisconsin
-$11.2M
3
TAM
THB Asset Management
Connecticut
-$5.61M
4
PWAM
Park West Asset Management
California
-$3.41M
5
RHJA
Rice Hall James & Associates
California
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$2.66M +$2.93M +36,473 +363%
Allianz Asset Management
27
Allianz Asset Management
Germany
$2.56M +$36.3K +451 +1%
Renaissance Technologies
28
Renaissance Technologies
New York
$2.51M -$791K -9,834 -18%
GA
29
Geneva Advisors
Illinois
$2.18M +$172K +2,141 +6%
TCM
30
Tygh Capital Management
Oregon
$2.01M -$899K -11,176 -24%
SC
31
Skylands Capital
Wisconsin
$1.78M -$1.01M -12,531 -29%
DGHMC
32
Dalton, Greiner, Hartman, Maher & Co
New York
$1.68M -$7.32K -91 -0.3%
LSC
33
Lyon Street Capital
California
$1.61M -$523K -6,503 -19%
TA
34
Teton Advisors
New York
$1.57M – – –
SI
35
Stephens Inc
Arkansas
$1.35M +$1.9M +23,625 New
US Bancorp
36
US Bancorp
Minnesota
$1.34M +$745K +9,255 +65%
SKK
37
Shepherd Kaplan Krochuk
Massachusetts
$1.2M -$328K -4,073 -16%
Deutsche Bank
38
Deutsche Bank
Germany
$1.1M +$754K +9,377 +95%
Two Sigma Investments
39
Two Sigma Investments
New York
$1.07M +$161K +1,998 +12%
BCA
40
Benchmark Capital Advisors
New York
$1.03M -$40.2K -500 -3%
GF
41
Gabelli Funds
New York
$909K – – –
CCP
42
Centaur Capital Partners
Texas
$887K -$684K -8,500 -35%
Asset Management One
43
Asset Management One
Japan
$760K +$224K +2,780 +26%
WIC
44
Woodmont Investment Counsel
Tennessee
$707K – – –
Bank of New York Mellon
45
Bank of New York Mellon
New York
$670K -$1.85K -23 -0.2%
KCM
46
Keane Capital Management
North Carolina
$630K +$224K +2,780 +34%
OAM
47
Oxford Asset Management
United Kingdom
$617K +$633K +7,865 +270%
AAP
48
Ardsley Advisory Partners
Connecticut
$601K – – –
Two Sigma Advisers
49
Two Sigma Advisers
New York
$576K -$9.65K -120 -1%
Arrowstreet Capital
50
Arrowstreet Capital
Massachusetts
$547K -$141K -1,756 -16%
1
2
3 4

TRIB Hedge Fund Activity: Q3 2015 in Review

92 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2015, worth a combined $212M — down 34% from $323M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new TRIB positions and 7 closed out — a net gain of 1 holder — while 40 added to existing stakes and 28 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $10M. The largest seller was William Blair & Company, cutting an estimated $11.9M.

  • 92 institutional investors held Trinity Biotech (TRIB) as of Q3 2015, unchanged from Q2 2015.
  • Funds reported $212M of Trinity Biotech stock for Q3 2015, down 34% quarter-over-quarter.
  • 8 funds opened new Trinity Biotech positions in Q3 2015 and 7 closed out, a net change of +1 holder.
  • The largest Trinity Biotech buyer in Q3 2015 was Janus Henderson Investors US, an estimated $10M added.
  • The largest Trinity Biotech seller in Q3 2015 was William Blair & Company, an estimated $11.9M sold.

Based on aggregated 13F filings for Q3 2015.